Home › Polycythemia Vera › North Carolina › Durham
Polycythemia Vera clinical trials in Durham, NC
5 studies for Polycythemia Vera are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Duke University Medical Center, Department of Hematologic Malignancies and Cellular Therapy, Durham
- University of North Carolina At Chapel Hill, Chapel Hill · 10 mi away
Registry of Older Patients With Cancer
RecruitingObservational study
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi away
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
RecruitingPhase 3
- DUHS Duke Blood Cancer Center ( Site 6005), Durham
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
RecruitingPhase 3
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RecruitingObservational study
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi away
Polycythemia Vera trials in other cities
- New York City, NY5 studies
- Irvine, CA3 studies
- Los Angeles, CA3 studies
- Tampa, FL3 studies
- Columbus, OH3 studies
- Nashville, TN3 studies
- Houston, TX3 studies
- Miami, FL3 studies
- Salt Lake City, UT3 studies
- Coral Springs, FL3 studies
Other studies in Durham
- Breast Cancer63 studies
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Metastatic Cancer33 studies
- Acute Myeloid Leukemia33 studies
- Lung Cancer32 studies
- Prostate Cancer32 studies
- Colorectal Cancer28 studies
- Chronic Lymphocytic Leukemia27 studies
- Ovarian Cancer27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.